-+ 0.00%
-+ 0.00%
-+ 0.00%

CYCLARITY THERAPEUTICS RECEIVES FDA INVESTIGATIONAL NEW DRUG CLEARANCE FOR UDP-003 TO EXPAND ATHEROSCLEROSIS CLINICAL DEVELOPMENT PROGRAM INTO THE UNITED STATES

Reuters·11/12/2026 19:36:03